Coprococcus eutactus: NCBI 33043, [species]

Back to details

| ATCC 27759| Coprococcus eutactus| Coprococcus eutactus Holdeman and Moore 1974

  1. Normal Gut Microbiota: Coprococcus bacteria, including Coprococcus eutactus, are part of the normal gut microbiota in humans. The gut microbiota plays a crucial role in various physiological functions, including digestion, metabolism, and immune system regulation.

  2. Anaerobic Bacteria: Coprococcus species are generally anaerobic bacteria, meaning they thrive in environments with little to no oxygen. Anaerobic bacteria are common inhabitants of the gut microbiota.

  3. Fermentation: Bacteria in the Coprococcus genus are known to be involved in the fermentation of dietary fibers and complex carbohydrates. During fermentation, these bacteria can produce short-chain fatty acids (SCFAs), which may have various health benefits.

  4. SCFA Production: Short-chain fatty acids, such as acetate, propionate, and butyrate, are metabolic byproducts of bacterial fermentation in the gut. SCFAs can contribute to maintaining gut health, influencing immune responses, and providing an energy source for the host.

  5. Associations with Diet: The abundance and composition of Coprococcus and other bacterial genera in the gut microbiota can be influenced by dietary factors. High-fiber diets, for example, are often associated with a more diverse gut microbiota, including the presence of bacteria capable of fermenting dietary fibers.

  6. Limited Specific Information: While Coprococcus is recognized as part of the normal gut microbiota, specific information about the health impacts of Coprococcus eutactus at the species level, including potential associations with health conditions, may not be well-documented.

Other Sources for more information:

You do not have any samples under this email

📹Video Walkthru of this Page

Coprococcus eutactus impacts on other bacteria of the same rank

Other bacteria of the same rank impacting Coprococcus eutactus

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]